Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Danske Bank

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 23
Average round size
info
The average size of a deal this fund participated in
$74M
Portfolio companies 18
Rounds per year 0.15
Lead investments 7
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.22
Exits 9
Key employees 25

Areas of investment

  • Banking
  • Payments
  • Information Technology
  • Real Estate
  • Biotechnology
Summary

In 1871 was created Danske Bank, which is appeared as Corporate Investor. The fund was located in Europe if to be more exact in Denmark. The leading representative office of defined Corporate Investor is situated in the Copenhagen.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The increased amount of exits for fund were in 2014. Comparing to the other companies, this Danske Bank performs on 9 percentage points less the average number of lead investments. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this Corporate Investor is 20 percentage points more often commits exit comparing to other companies.

The standard case for the fund is to invest in rounds with 5-6 partakers. The meaningful sponsors for the fund in investment in the same round are DNB, Westpac, Wells Fargo. In the next rounds fund is usually obtained by Index Ventures, SLS Venture, Novo Holdings.

The overall number of key employees were 25.

Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Financial Services, Biopharma. Among the most popular portfolio startups of the fund, we may highlight R3, Devenish Nutrition, Gilfresh Produce. For fund there is a match between the location of its establishment and the land of its numerous investments - Denmark.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Danske Bank:
1 DNB
Typical Co-investors
Danske Bank is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Danske Bank:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Acappella Partners -
Allston Venture Fund Allston, Massachusetts, United States
Alto Partners Multi-Family Office Central Region, Singapore, Singapore
Calibrate Ventures California, Pasadena, United States
Daiwa PI Partners Japan, Tokyo
Early Impact Ventures California, San Francisco, United States
Elige Capital France, Ile-de-France, Paris
Filtro Private Equity ( Silicon Valley ) California, San Francisco, United States
GLG Green Lifestyle Germany, Hamburg
Hezhihe Chuangtou China, Guangdong, Shenzhen
Impact Collective -
Jinsanban Touzi China, Huangpu, Shanghai
Pacifica Enterprises -
Paramount Capital Memphis, Tennessee, United States
PCRS Capital Partners California, Long Beach, United States
SABEY Seattle, United States, Washington
Vanguard Ventures California, San Jose, United States
Wuliangye Yibin China, Sichuan, Yibin
Zhejiang State Enterprise Reform and Development Fund China, Hangzhou, Zhejiang
Zhongdian Health Industry Fund Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Symphogen

Biopharma
Biotechnology
Drug Discovery
Pharmaceutical
$15M22 Jan 2002 Denmark, Capital Region of Denmark, Denmark
News
Anocca Raises $47m in a Series B Financing to Advance Its Industrialised Approach to TCR-T Cellular Immunotherapy

– Anocca AB closed a $47m Series B financing to further advance the company’s industrialised cellular biology platform and progress its pipeline of TCR-T cellular therapies into Phase I/IIa clinical trials.
– The financing was led by advisor Danske Bank, with Swedbank Robur Ny Teknik, Ramsbury Invest and significant family offices including those of Harald Mix and Robert Andreen joining existing investors including Mellby Gård, Nidoco and co-founder Mikael Blomqvist.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Danske Bank?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 23
Average round size 74M
Rounds per year 0.15
Peak activity year 2018
Lead investments 7
Follow on index 0.22
Exits 9
Group Appearance index 0.61

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Symphogen

Biopharma
Biotechnology
Drug Discovery
Pharmaceutical
$15M22 Jan 2002 Denmark, Capital Region of Denmark, Denmark
Crunchbase icon

Content report

The following text will be sent to our editors: